IDNLearn.com offers a comprehensive solution for finding accurate answers quickly. Discover comprehensive answers to your questions from our community of experienced professionals.
Sagot :
Final answer:
The drug combination relieves hot flashes and prevents osteoporosis but does not reduce the risk of ovarian cancer.
Explanation:
Reduces the risk of ovarian cancer: The combination of transdermal conjugated estrogen and medroxyprogesterone does not reduce the risk of ovarian cancer.
Relieves hot flashes: This drug combination helps in relieving hot flashes, a common symptom of menopause.
Prevents osteoporosis: It aids in preventing osteoporosis by reducing the loss of calcium from bones.
Learn more about Menopausal hormone therapy here:
https://brainly.com/question/32155538
Thank you for using this platform to share and learn. Keep asking and answering. We appreciate every contribution you make. Thank you for trusting IDNLearn.com. We’re dedicated to providing accurate answers, so visit us again for more solutions.